Foley Hoag Partners Bryant Godfrey and August Horvath Contribute to 2022 Chambers Global Practice Guide on Pharmaceutical Advertising

March 29, 2022

Foley Hoag LLP partners Bryant Godfrey and August Horvath authored the new “USA: Trends and Developments” chapter of the recently released 2022 Chambers Global Practice Guide on Pharmaceutical Advertising. The guide offers an analysis of key market trends and developments in pharmaceutical advertising in the U.S., as well as an overview of the related regulatory and legal environment.

Godfrey is a member of Foley Hoag’s FDA practice, where he provides strategic regulatory advice to large pharmaceutical, medical device and biotech companies, start-ups, and trade associations, helping them to navigate challenges relating to the development, manufacturing, approval and promotion of drugs, biologics, medical devices, and combination products.

Horvath is a member of Foley Hoag's Advertising & Marketing practice, where he counsels clients on how to substantiate and defend marketing claims they wish to make for their products and services, helps them challenge false and disparaging advertising by their competitors, and assists them in managing relationships with competitors, customers and suppliers without running afoul of antitrust laws.

Click here to view the 2022 Chambers Global Practice Guide on Pharmaceutical Advertising – USA: Trends and Developments.

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and business services professionals contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.